About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Houston | 515 Studies

Clinical Trials Prostate CancerHouston

Prostate Cancer Clinical Trials in Houston

Find 515 clinical trials for prostate cancer near Houston, Texas. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-60 of 515 trials

Active not recruitingLifestyle Behavior Influences Among African American Patients With Stage 0-III Prostate Cancer Survivors and Their PartnersThis trial studies the day-to-day stress, social support, and health lifestyle behaviors (such as physical activity and nutrition) in African American patients with stage 0-III…NCT04189770·Houston, Texas CompletedThe Effects of Radium-223 Dichloride Therapy on Radionuclide Bone Scan Lesions.To describe the changes seen on bone scan and correlate them with changes in relative chemical biomarkers, patient's functional status and level of pain.NCT03368989·Houston, Texas CompletedRandomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-resistant Prostate CancerThe purpose of this study is to determine whether survival can be prolonged in patients with castration-resistant prostate cancer who receive dasatinib with docetaxel and…NCT00744497·Mobile, Alabama and 185 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedA Phase 1 Study of MDV3100 in Patients With Castration-Resistant (Hormone-Refractory) Prostate CancerThis is a multi-center open-label dose-escalation study of a novel compound (MDV3100) to treat patients with castration-resistant (hormone-refractory) prostate cancer.NCT00510718·Boston, Massachusetts and 8 others

Completed68 Ga-PSMA for High Risk Prostate CancerThis is a prospective, single-center, open-label pilot study of 68GA-PSMA-11 given at a single time prior to PET/CT imaging in men with localized high risk prostate cancer or…NCT04614363·Houston, Texas

CompletedTelomere Associated Variables (TAVs) in Prostate CancerThis research project results from the interest in continuing the collaboration with the previous LL-HURS-ONC001 clinical validation study, which gives cause to the present study.NCT04124900·Hialeah, Florida and 9 others

CompletedZoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone MetastasesRATIONALE: Zoledronate may prevent or decrease skeletal (bone)-related events (such as pain or fractures) caused by bone metastases and androgen deprivation therapy.NCT00079001·Mobile, Alabama and 240 others

RecruitingA Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid TumorsThis is a Phase 1, first-in-human (FIH), open-label, multicenter study designed to evaluate the safety, tolerability, PK, and preliminary anti-tumor activity of SHY-ONC6 in…NCT07705334·Scottsdale, Arizona and 3 others

RecruitingA Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid TumorsThe goal of this clinical trial is to evaluate whether TJ101, an investigational antibody-drug conjugate (ADC), can safely and effectively treat patients with advanced solid…NCT07181473·Orlando, Florida and 6 others

TerminatedA Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid TumorsThe purpose of the trial is to evaluate the safety, determine the recommended Phase 2 dose (RP2D), and assess preliminary clinical activity of GEN1044 in patients with solid…NCT04424641·Nashville, Tennessee and 5 others

RecruitingPROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.1. Personalize treatment for prostate cancer based on how aggressive the disease is and 2.NCT06274047·Gilbert, Arizona and 5 others

RecruitingA Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)The purpose of this study is to evaluate the safety, efficacy, tolerability, and pharmacokinetics (PK) of FG-3246, a cluster of differentiation 46 (CD46) targeting antibody-drug…NCT06842498·Goodyear, Arizona and 22 others

UnknownRadiation Therapy for Rising Prostate Specific Antigen (PSA) Post-prostatectomyThe goal of this clinical research study is to create a registry (research database) of clinical data about patients who receive radiation therapy, with or without hormone…NCT00850941·Albuquerque, New Mexico and 2 others

CompletedStudy of VERU-944 to Ameliorate Hot Flashes in Men With Advanced Prostate CancerRandomized, double-blind, placebo controlled, dose finding Phase 2 study comparing oral daily dosing of VERU-944 after a week of loading (daily dosing) with placebo to ameliorate…NCT03646162·Glendale, Arizona and 23 others

CompletedStudy to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and AnorexiaStudy to compare the effects of the investigational new drug (PF-06946860) and a placebo on appetite and to find out how participants with advanced cancer and anorexia feel after…NCT04803305·Little Rock, Arkansas and 32 others

Active not recruitingPhase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate CancerThe purpose of this study is to evaluate the effectiveness of ProstAtak® immunotherapy in combination with radiation therapy for patients with intermediate-high risk localized…NCT01436968·Gilbert, Arizona and 72 others

RecruitingAn Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate CancerTo learn if using cryotherapy to treat only the part of the prostate known to contain cancer is effective in controlling prostate cancerNCT05454488·Houston, Texas

Active not recruitingStudy of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 MutationsThis is an open-label, multicenter Phase 1 study to evaluate safety, tolerability and preliminary efficacy of oral LY3410738 in patients with isocitrate dehydrogenase 1 (IDH1)…NCT04521686·Phoenix, Arizona and 32 others

CompletedS0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone TherapyRATIONALE: Drugs used in chemotherapy, such as docetaxel, prednisone, and atrasentan work in different ways to stop the growth of tumor cells, either by killing the cells or by…NCT00134056·Mobile, Alabama and 553 others

Active not recruitingA Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate CancerTo evaluate whether Fuzuloparib plus AA-P is superior to placebo plus AA-P as first-line treatment by assessment of radiographic progression-free survival (rPFS) in mCRPC subjects…NCT04691804·Anchorage, Alaska and 146 others

PreviousPage 3 of 26Next

Other Conditions in Houston

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma